-
1Academic Journal
Authors: A. N. Letuchikh, A. S. Ablyametova, A. V. Zorinova, E. R. Israelyan, A. S. Tsareva, A. A. Rumyantsev, А. Н. Летучих, А. С. Абляметова, А. В. Зоринова, Э. Р. Исраелян, А. С. Царева, А. А. Румянцев
Contributors: The article was prepared without sponsorship., Статья подготовлена без спонсорской поддержки.
Source: Malignant tumours; Том 14, № 4 (2024); 84-90 ; Злокачественные опухоли; Том 14, № 4 (2024); 84-90 ; 2587-6813 ; 2224-5057
Subject Terms: определение аллелей партнера в опухолевом материале, non-gestational choriocarcinoma of the ovaries, gestational choriocarcinoma of the ovaries, molecular-genetic testing, determination of alleles of the partner in tumor material, негестационная хориокарцинома яичников, гестационная хориокарцинома яичников, молекулярно-генетическое тестирование
File Description: application/pdf
Relation: https://www.malignanttumors.org/jour/article/view/1324/1027; Bishop B.N., Edemekong P.F. Choriocarcinoma. In: StatPearls. Treasure Island (FL): StatPearls Publishing; February 4, 2023. PMID: 30571055; Liu X., Zhang X., Pang Y., et al. Clinicopathological factors and prognosis analysis of 39 cases of non-gestational ovarian choriocarcinoma. Arch Gynecol Obstet 2020;301(4):901–912. https://doi.org/10.1007/s00404-020-05502-9; Hayashi S., Abe Y., Tomita S., et al. Primary non-gestational pure choriocarcinoma arising in the ovary: A case report and literature review. Oncol Lett 2015;9(5):2109–2111. https://doi.org/10.3892/ol.2015.2985; Vance R.P., Geisinger K.R. Pure nongestational choriocarcinoma of the ovary. Report of a case. Cancer 1985;56(9):2321– 2325. https://doi.org/10.1002/1097-0142(19851101)56:93.0.co;2-q; Exman P., Takahashi T.K., Gattas G.F., et al. Primary ovary choriocarcinoma: individual DNA polymorphic analysis as a strategy to confirm diagnosis and treatment. Rare Tumors 2013;5(2):89–92. https://doi.org/10.4081/rt.2013.e24; Lv L., Yang K., Wu H., et al. Pure choriocarcinoma of the ovary: a case report. J Gynecol Oncol 2011;22(2):135–9. https://doi.org/10.3802/jgo.2011.22.2.135; Fisher R.A., Newlands E.S., Jeffreys A.J., et al. Gestational and nongestational trophoblastic tumors distinguished by DNA analysis. Cancer 1992;69(3):839–845. https://doi.org/10.1002/1097-0142(19920201)69:33.0.co;2-e; Adow M.T., Gebresilasie S.F., Abebe N.A. Primary ovarian choriocarcinoma: rare entity. Case Rep Obstet Gynecol 2021;2021:4545375. https://doi.org/10.1155/2021/4545375; Тюляндина А.С., Коломиец Л.А., Морхов К.Ю. и соавт. Практические рекомендации по лекарственному лечению рака яичников, первичного рака брюшины и рака маточных труб. Практические рекомендации RUSSCO, часть 1. Злокачественные опухоли 2023;13(3s2):201–215.; Гуторов С.Л., Новикова Е.Г., Румянцев А.А., и соавт. Практические рекомендации по лекарственному лечению злокачественных неэпителиальных опухолей яичников. Практические рекомендации RUSSCO, часть 1. Злокачественные опухоли 2023;13(3s2):216–234.; NCCN Guidelines, Version 1.2024. Gestational Trophoblastic Neoplasia. Available at: https://www.nccn.org/professionals/physician_gls/pdf/gtn.pdf; NCCN Guidelines, Version 1.2024. Testicular Cancer. Available at: https://www.nccn.org/professionals/physician_gls/pdf/testicular.pdf; Shao Y., Xiang Y., Jiang F., et al. Clinical features of a Chinese female nongestational choriocarcinoma cohort: a retrospective study of 37 patients. Orphanet J Rare Dis 2020;15(1):325. https://doi.org/10.1186/s13023-020-01610-6; Yu X., Du Q., Zhang X., et al. Pure primary non-gestational choriocarcinoma originating in the ovary: A case report and literature review. Rare Tumors 2021;13:20363613211052506. https://doi.org/10.1177/20363613211052506; Kong B., Tian Y.J., Zhu W.W., Qin Y.J. A pure nongestational ovarian choriocarcinoma in a 10-year-old girl: case report and literature review. J Obstet Gynaecol Res 2009;35(3):574–578. https://doi.org/10.1111/j.1447-0756.2008.00973.x; Lorigan P.C., Grierson A.J., Goepel J.R., et al. Gestational choriocarcinoma of the ovary diagnosed by analysis of tumour DNA. Cancer Lett 1996;104(1):27–30. https://doi.org/10.1016/0304-3835(96)04219-x; Zhang X., Yan K., Chen J., Xie X. Using short tandem repeat analysis for choriocarcinoma diagnosis: a case series. Diagn Pathol 2019;14:93. https://doi.org/10.1186/s13000-019-0866-5; Alifrangis C., Agarwal R., Short D., et al. EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis. J Clin Oncol 2013;31(2):280–286. https://doi.org/10.1200/JCO.2012.43.1817; You B., Bolze P.A., Lotz J.P., et al. Avelumab in patients with gestational trophoblastic tumors with resistance to single-agent chemotherapy: Cohort A of the TROPHIMMUN phase II trial. J Clin Oncol 2020;38(27):3129–3137. https://doi.org/10.1200/JCO.20.00803; You B., Bolze P.A., Lotz J.P., et al. Avelumab in patients with gestational trophoblastic tumors with resistance to polychemotherapy: Cohort B of the TROPHIMMUN phase 2 trial. Gynecol Oncol 2023;168:62–67. https://doi.org/10.1016/j.ygyno.2022.11.005; Yang Y., Zhang X., Chen D., et al. Adolescent non-gestational ovarian choriocarcinoma: report of a case and review of literature. Int J Clin Exp Pathol 2019;12(5):1788–1794. PMID: 31933999; Yamamoto E., Ino K., Yamamoto T., et al. A pure nongestational choriocarcinoma of the ovary diagnosed with short tandem repeat analysis: case report and review of the literature. Int J Gynecol Cancer 2007 Jan-Feb;17(1):254–258. https://doi.org/10.1111/j.1525-1438.2006.00764.x; Tsujioka H., Hamada H., Miyakawa T., et al. A pure nongestational choriocarcinoma of the ovary diagnosed with DNA polymorphism analysis. Gynecol Oncol 2003;89(3):540–542. https://doi.org/10.1016/s0090-8258(03)00139-2.; https://www.malignanttumors.org/jour/article/view/1324